PHVS – pharvaris n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference [Yahoo! Finance]
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
Pharvaris (PHVS) had its "buy" rating reaffirmed by Citigroup Inc..
Pharvaris (PHVS) was downgraded by Wall Street Zen from "sell" to "st
Pharvaris (PHVS) was upgraded by Wolfe Research to "strong-buy".
Form 144 Pharvaris N.V. Filed by: Modig Berndt
Form 4 Pharvaris N.V. For: Apr 14 Filed by: Nijdam Anna
Form 4 Pharvaris N.V. For: Apr 09 Filed by: Modig Berndt
Form 144 Pharvaris N.V. Filed by: Modig Berndt
Form 4 Pharvaris N.V. For: Apr 06 Filed by: Nijdam Anna
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.